Investors may be taking a second look at shares of Portola Pharma (PTLA). After a recent check, we can see that the beta research opinion is currently Buy. This signal uses a system combining volatility, momentum, and wave theory to help spot the general trend. In terms of direction, the signal is currently Weakest. This signal may indicate if the Buy or Sell is weakening or gaining strength, or if the Hold is leaning towards a Buy or Sell. The beta research strength signal is currently Weak. This signal is compared to the historical performance where maximum would be considered the strongest, and minimum would be seen as the weakest. 

Active investors are constantly faced with tough decisions when managing their own stock portfolios. Deciding when to sell a certain stock may be just as vital as choosing which stocks to buy in the first place. There are bound to be extremes on both sides when analyzing buy and sell decisions. Maybe a well researched stock hasn’t seen the gains that were expected at the outset. When emotions take over, the investor may not be able to part with the stock. They may hold on to the equity with the hopes that someday it will bounce back. Of course this may happen eventually, but the situation could also worsen and the stock may keep losing. The same decisions sometimes have to be made when dealing with a winning stock. After a big run, the investor may have to decide whether to take the profits or hold off to see if the stock will continue to push upwards. These are no easy decisions for the individual investor. Being able to make the proper portfolio moves may take some time to master, but it may end up being highly important for continued, long-term success.  

Taking a look at some indicators on shares of Portola Pharma (PTLA), we note that the reading from the 40-day commodity channel index is currently Hold. The CCI indicator is primarily used to identify oversold and overbought levels. The signal direction is currently Bearish. Checking on the 50-day parabolic time/price signal, we can see the signal is presently Buy. The signal direction is currently reading Weakest. Investors may opt to study a variety of different indicators in order to gain further insight on company share action. Traders may have increased interest when shares are nearing key support and resistance levels.

Tracking current trading session activity on shares of Portola Pharma (PTLA), we can see that the stock price recently hit 35.24. Since the start of the session, the stock has reached a high of 36.89 and hit a low of 35.23. Focusing in on some other information, we can see that the stock has a current weighted alpha of +18.50. The weighted alpha measures how much the stock has increased or decreased over the period of one full year. The weighting puts greater emphasis on more recent activity offering a more relevant measure for short-term technical analysts to use. A positive weighted alpha reading indicates that shares have risen over the past year. A negative reading would indicate that the stock is down over that same time period. Technical traders often use the weighted alpha to help discover stocks that are developing momentum. Current and potential shareholders will be earnestly watching to see how the stock performs as we near the midway point of the calendar year.

Portola Pharma (PTLA) currently has 5 day MA of 36.57. Investors may use moving averages for multiple purposes. Some may use the moving average as a primary trading tool, while others may use it as a back-up. Investors may be looking for when the stock price crosses a certain moving average and then closes on the other side. These moving average crossovers may be used to help identify momentum shifts, or possible entry/exit points. A cross below a particular moving average may signal the start of a downward move. On the other end, a cross above a moving average may suggest a possible uptrend. Investors may be focused on many different time periods when studying moving averages. The stock currently has a 200 day MA of 27.99.

It is no secret that most investors have the best of intentions when diving into the equity markets. Making sound, informed decisions can help the investor make the most progress when dealing with the markets. Often times, investors may think they have everything in order, but they still come out on the losing end. Investors may need to figure out ways to keep emotion out of stock picking. Sometimes trading on emotions can lead to poor results. Making hasty decisions and not paying attention to the correct data can lead to poor performing portfolios in the long-term.